| scholarly article | Q13442814 |
| P50 | author | Sergey Kozin | Q57418276 |
| Maria Zharkova | Q61130823 | ||
| Igor A. Popov | Q64545153 | ||
| P2093 | author name string | Alexey B Mantsyzov | |
| Eugene N Nikolaev | |||
| Elena V Kugaevskaya | |||
| Nina I Solovyeva | |||
| Alexander A Makarov | |||
| Alexander V Veselovsky | |||
| Maria I Indeykina | |||
| P2860 | cites work | Crystal structure of the human angiotensin-converting enzyme-lisinopril complex | Q24293072 |
| Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning | Q24293181 | ||
| Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides | Q24309254 | ||
| Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides | Q24314883 | ||
| NMR solution structure of rat aβ(1-16): toward understanding the mechanism of rats' resistance to Alzheimer's disease | Q24615365 | ||
| Improved side-chain torsion potentials for the Amber ff99SB protein force field | Q24616749 | ||
| Cerebrovascular disease in ageing and Alzheimer's disease | Q26771852 | ||
| Comparison of simple potential functions for simulating liquid water | Q26778447 | ||
| Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease | Q26810028 | ||
| Self-propagation of pathogenic protein aggregates in neurodegenerative diseases | Q26996441 | ||
| Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides | Q27674442 | ||
| Structural studies of the tethered N-terminus of the Alzheimer's disease amyloid-β peptide | Q27684462 | ||
| UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| GROMACS: fast, flexible, and free | Q27860998 | ||
| Three dimensions of the amyloid hypothesis: time, space and 'wingmen' | Q28082768 | ||
| Alzheimer's disease: genes, proteins, and therapy | Q28131806 | ||
| Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host | Q28264821 | ||
| The renin-angiotensin and the kallikrein-kinin systems | Q28609697 | ||
| 3D structure of Alzheimer's amyloid-beta(1-42) fibrils | Q29617475 | ||
| Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards | Q30891249 | ||
| Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity | Q31017305 | ||
| Absolute quantitation of proteins by a combination of acid hydrolysis and matrix-assisted laser desorption/ionization mass spectrometry | Q31086217 | ||
| Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging | Q33227600 | ||
| The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser [...] | Q33310715 | ||
| Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies | Q33893017 | ||
| Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states | Q34006345 | ||
| Ace revisited: a new target for structure-based drug design. | Q34282839 | ||
| ACE variants and association with brain Aβ levels in Alzheimer's disease | Q34310258 | ||
| Catalytic mechanism of angiotensin-converting enzyme and effects of the chloride ion. | Q34344605 | ||
| Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression | Q34358030 | ||
| Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor | Q34449990 | ||
| Interplay of histidine residues of the Alzheimer's disease Aβ peptide governs its Zn-induced oligomerization | Q34514957 | ||
| Vascular basis for brain degeneration: faltering controls and risk factors for dementia | Q34680483 | ||
| Inhibitor and substrate binding by angiotensin-converting enzyme: quantum mechanical/molecular mechanical molecular dynamics studies. | Q35167293 | ||
| Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis | Q35327172 | ||
| Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice | Q35913908 | ||
| MCPB.py: A Python Based Metal Center Parameter Builder | Q35935286 | ||
| Structure of angiotensin I-converting enzyme. | Q35953147 | ||
| Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact | Q36416236 | ||
| Update on hypertension and Alzheimer's disease | Q36582774 | ||
| The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis | Q36807001 | ||
| Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia | Q36989228 | ||
| Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme. | Q37107046 | ||
| ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease | Q37139242 | ||
| Vascular risk factor detection and control may prevent Alzheimer's disease | Q37729423 | ||
| Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? | Q37961852 | ||
| Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. | Q38095693 | ||
| The broad substrate specificity of human angiotensin I converting enzyme | Q38177064 | ||
| Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex | Q40032135 | ||
| Zinc-induced heterodimer formation between metal-binding domains of intact and naturally modified amyloid-beta species: implication to amyloid seeding in Alzheimer's disease? | Q40380036 | ||
| Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence | Q40789635 | ||
| Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. | Q41840991 | ||
| Structural Survey of Zinc-Containing Proteins and Development of the Zinc AMBER Force Field (ZAFF) | Q42425546 | ||
| Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease | Q42971709 | ||
| Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases | Q43589840 | ||
| Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias | Q44564946 | ||
| Identification of the minimal zinc-binding center in natural isoforms of amyloid-beta domain 1-16 using ESI-MS | Q45258628 | ||
| Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. | Q46942783 | ||
| Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme | Q48446299 | ||
| Arginine specific endopeptidases modify the aggregation properties of a synthetic peptide derived from Alzheimer beta/A4 amyloid | Q48499542 | ||
| Angiotensin Converting Enzyme in Alzheimer's Disease: Increased Activity in Caudate Nucleus and Cortical Areas | Q48952014 | ||
| Peripherally applied synthetic peptide isoAsp7-Aβ(1-42) triggers cerebral β-amyloidosis. | Q50996852 | ||
| Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study. | Q51893818 | ||
| The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide. | Q53268032 | ||
| Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. | Q53319221 | ||
| Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease. | Q53460930 | ||
| Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems | Q56750591 | ||
| Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease | Q57278129 | ||
| Amyloid-β containing isoaspartate 7 as potential biomarker and drug target in Alzheimer's disease | Q57721654 | ||
| ESI-MS identification of the minimal zinc-binding center in natural isoforms of β-amyloid domain 1–16 | Q57721717 | ||
| Capabilities of MS for Analytical Quantitative Determination of the Ratio of α- and βAsp7 Isoforms of the Amyloid-β Peptide in Binary Mixtures | Q57721733 | ||
| Zinc Binding to Alzheimer's Aβ(1–16) Peptide Results in Stable Soluble Complex | Q57721764 | ||
| Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy | Q58477361 | ||
| Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population | Q73375117 | ||
| Alzheimer's disease | Q80270542 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 298 | |
| P577 | publication date | 2018-01-10 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease | |
| P478 | volume | 8 |
| Q64091575 | Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer's disease |
| Q57721642 | Intravenously Injected Amyloid-β Peptide With Isomerized Asp7 and Phosphorylated Ser8 Residues Inhibits Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice Model of Alzheimer's Disease |
| Q89876372 | Using human genetics to guide the repurposing of medicines |
Search more.